British Journal of Haematology · 2003 · 35 citations · 7 references
Life SciencesGeneticsMolecular GeneticsCytogeneticsGenomicsMolecular OncologyAneuploidyHematopoietic NeoplasmsMyelodysplastic SyndromesMyeloid-derived Suppressor CellsFusion Transcript AnalysisFusion Transcript DetectionHematologic Malignancy FusionsTherapy-related Myelodysplastic Syndromes
We report a case of therapy-related myelodysplastic syndrome (t-MDS) with t(10;16)(q22;p13), in which novel fusion transcripts of the MORF and CBP genes were detected. In one MORF-CBP fusion transcript, exon 15 of the MORF gene was fused in frame with exon 5 of the CBP gene. In a reciprocal CBP-MORF transcript, exon 4 of the CBP gene was fused in frame with exon 16 of the MORF gene. This is the first reported case of t-MDS associated with t(10;16), and provides molecular evidence that the novel MORF-CBP and/or CBP-MORF fusion protein(s) might play an important role in the development of t-MDS.
7
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)
JG Dauwerse, Christine M. Higgins, Fred Petrij et al. · Leukemia · 1997 · 84 citations
AnneMarie W. Block, Andrew J. Carroll, Anne Hagemeijer et al. · Genes Chromosomes and Cancer · 2002 · 67 citations
Life Sciences, Genetics, Hematology +17